Report Highlights
The global cell separation techniques market should reach $4.4 billion by 2026 from $3.1 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
Report Includes
- 35 data tables and 17 additional tables
- An overview of the global market for cell separation techniques with focus on magnetic and flow-based models
- Estimation of the market size and analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the current and future market potential, evaluation of market size and forecast, and segmentation of cell separation technologies products by research applications, end users and region
- Discussion on antibody-based drug discovery and development, trends in research antibody market, new discoveries in biological sciences and identification of market drivers, restraints and opportunities
- Information on immunomagnetic cell separation and Fluorescence-activated cell sorting (FACS) and coverage of their methods and benefits
- Discussion of the current strategies of cell separation companies, effect of research funding and third-party quality evaluation systems of cell separation techniques
- Detailed analysis of the regulatory framework and policies, and reimbursement scenarios
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry, including BD Biosciences, Bio-Rad Laboratories Inc., Millipore-Sigma, and Thermo Fisher Scientific
Report Scope
This report will provide details about cell separation techniques used in the treatment of autoimmune disease and how the market has been influenced by COVID-19. This report will also highlight the current and future market potential of cell separation techniques with detailed analyses of the competitive environments between companies. Drivers, restraints, opportunities, value chain analysis, prevalence or incidence of cancer, and regulatory scenarios will also be covered. The report includes a market projection for 2026 and market shares of key players.
This study focuses on the market side of cell separation technologies that focus on magnetic and flow-based models rather than technical features. Different market segments are covered. For example, application-based market segments include stem cell research, neuroscience, immunology, cancer science and others (trauma, surgery, etc.); customer type-based market segments include hospitals/diagnostic labs, universities/academic institutions, pharmaceutical/biotech companies and other types of customers such as governmental research labs and CROs.
By geography, the market has been segmented into North America, Europe, the Asia-Pacific, Latin America and the Middle East Africa. A detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, the Gulf Cooperation Council countries and South Africa will be covered in the regional segments. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast values for 2026.
- Regional splits.
- Country level segmentation.
- Market insights such as the impact of COVID-19 and regulations.
- Competitive share analysis of companies.
- Segmentation by technology.
- Expansion of indication segments.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Prenatal Testing Market (MDS103A)
- Companion Diagnostics: Technologies and Markets (BIO077F)
- Global Markets, Technologies and Materials for Thin and Ultrathin Films (SMC057D)
- Molecular Farming: Global Markets (CHM187A)
- Exosome Diagnostics, Therapeutics and Research Tools: Global Markets (BIO149E)
Related Reports
Global Markets for Research Antibodies
The global market for research antibodies is estimated to increase from $3.7 billion in 2023 to reach $5.8 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
Global Markets and Technologies for Cell and Tissue Analysis
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry is estimated to increase from $5.2 billion in 2022 to reach $7.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Autoimmune Disorder Therapies: Global Markets
The global market for autoimmune disorder therapies should grow from $53.2 billion in 2019 to $90.7 billion by 2024 with a compound annual growth rate (CAGR) of 11.2% for the period of 2019-2024.
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More